This webinar has now concluded

Review of the Induced Proximity Landscape

As PROTACs advance, vast untapped potential lies in heterobifunctional and monovalent approaches. However, challenges such as knowledge gaps in validating novel mechanisms of action and the complexity of designing new target spaces remain.

To address these challenges, our lead research analyst, Katie Spooner, provided an in-depth analysis of the induced proximity landscape for the recent 4th Induced Proximity-Based Drug Discovery Summit in Boston.

Induced Proximity Landscape Webinar

This video analysis provides a brief overview of the wider TPD space, considering drug status and the growth of modalities, a deep dive into novel induced proximity modalities, and an analysis of the induced proximity deals and companies landscape. Watch the video now.

You May Also Be Interested In…

What is Beacon?

Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more

Menu
Search Icon
Close Icon
Search